A randomized placebo-controlled phase I clinical trial to evaluate the immunomodulatory activities of Atractylodes lancea (Thunb) DC. in healthy Thai subjects

Abstract Background Atractylodes lancea (Thunb) DC. (AL) and bioactive compounds β-eudesmol and atractylodin have been demonstrated in the in vitro and in vivo studies for their potential clinical use in cholangiocarcinoma. The study was a randomized, double-blinded, placebo-controlled phase I clini...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Inthuon Kulma, Luxsana Panrit, Tullayakorn Plengsuriyakarn, Wanna Chaijaroenkul, Siriprapa Warathumpitak, Kesara Na-Bangchang
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2021-02-01
coleção:	BMC Complementary Medicine and Therapies
Assuntos:	Atractylodes lancea β-Eudesmol Atractylodin Cholangiocarcinoma Immunomodulatory activity
Acesso em linha:	https://doi.org/10.1186/s12906-020-03199-6
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!